Physician

Dhanunjaya Lakkireddy, MD

According to 2025 Medicare claims, Dhanunjaya Lakkireddy, MD (NPI: 1023067881) practices cardiology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is MIDWEST HEART & VASCULAR SPECIALISTS, LLC (NPI: 1760736615; TIN: 800841009) and primary practice location at 66211-1215. Lakkireddy is affiliated with the Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Lakkireddy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 964 traditional Medicare patients, billed 6,623 HCPCS/CPT codes, and received $548,405 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,991 prescription claims across 491 beneficiaries totaling $631,664 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 330 records totaling $984,936. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $286,950 to $548,405. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $488,193 and ending at $631,664. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	702	3,157	$286,950
2016	936	3,666	$243,358
2017	940	3,950	$271,532
2018	737	2,816	$228,135
2019	581	4,473	$342,742
2020	534	3,987	$375,022
2021	678	3,652	$359,039
2022	708	3,612	$318,889
2023	689	4,723	$325,656
2024	964	6,623	$548,405

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	411	3,230	$488,193
2016	450	3,590	$594,001
2017	490	3,756	$567,539
2018	501	3,020	$495,775
2019	342	2,258	$389,700
2020	354	2,193	$403,019
2021	401	2,252	$438,145
2022	419	1,967	$359,382
2023	437	2,364	$548,582
2024	491	2,991	$631,664

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	394	667	$96
93298	Evaluation of cardiac rhythm monitor system, remote up to 30 days	435	2,679	$76
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	153	190	$63
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	213	499	$16
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	395	692	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	275	12,309	$236,663
Xarelto	Rivaroxaban	153	7,459	$136,513
Entresto	Sacubitril/Valsartan	79	4,980	$110,991
Dofetilide	Dofetilide	231	15,727	$40,759
Multaq	Dronedarone Hcl	18	1,020	$25,920

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	237	$145,419	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	93	$839,516	Biosense Webster, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dhanunjaya Lakkireddy, MD?

Tedicare shows public-source Medicare data for Dhanunjaya Lakkireddy, MD (NPI 1023067881), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dhanunjaya Lakkireddy, MD have ACO affiliation data?

Dhanunjaya Lakkireddy, MD is shown with ACO affiliation data for Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Dhanunjaya Lakkireddy, MD?

Dhanunjaya Lakkireddy, MD is linked to MIDWEST HEART & VASCULAR SPECIALISTS, LLC (billing NPI 1760736615) in the available physician profile data.

Does Dhanunjaya Lakkireddy, MD have Open Payments data?

Dhanunjaya Lakkireddy, MD has 330 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.